Complications and prostate cancer diagnosis rate of TRUS prostate biopsies using 16 and 18G needles by Clavien scoring

Basit Öğe Kaydı
dc.contributor.authorOzcan, Serkan
dc.contributor.authorDiri, Mehmet Akif
dc.contributor.authorBagcioglu, Murat
dc.contributor.authorKarakan, Tolga
dc.contributor.authorAydin, Arif
dc.date.accessioned2024-02-23T14:41:30Z
dc.date.available2024-02-23T14:41:30Z
dc.date.issued2017
dc.departmentNEÜen_US
dc.description.abstractAim: We aimed to compare the 18 and 16-Gauge (G) needles used in transrectal ultrasonography (TRUS)-guided needle biopsy for cancer detection rates and complications using the Clavien Scoring System. Materials and methods: The 80 patients who were included in the study were randomized and divided into two groups. Group 1 (n = 36) had a TRUS-guided prostate biopsy with an 18G needle and Group 2 had a 16G needle (n = 44). The hematuria, bleeding assessment, and infection events were evaluated on a daily basis. These complications were graded according to the Clavien Scoring. Results: In Group 1, only five (13%) patients were diagnosed with prostate cancer, and three patients were reported to have atypical small acinar proliferation (ASAP). In Group 2, 16 (36%) patients were diagnosed with prostate cancer and one patient was reported to have ASAP. The difference in the prostate cancer detection rate between the groups was statistically significant. According to the Clavien grading system, the complications were at the Grade 1 level in 25 people in Group 1 in 29 people in Group 2. Grade 2 level complications were not observed in either group. While one person was Grade 3 in Group 1, two people in Group 2 had this rate. There were no significant differences between the groups. Conclusions: We found that cancer detection rate increased by increasing the thickness of the needle used in TRUS-guided prostate biopsy without any increase in the complications.en_US
dc.identifier.doi10.5301/uj.5000238
dc.identifier.endpage239en_US
dc.identifier.issn0391-5603
dc.identifier.issn1724-6075
dc.identifier.issue4en_US
dc.identifier.pmid28525666en_US
dc.identifier.scopusqualityQ4en_US
dc.identifier.startpage236en_US
dc.identifier.urihttps://doi.org/10.5301/uj.5000238
dc.identifier.urihttps://hdl.handle.net/20.500.12452/16865
dc.identifier.volume84en_US
dc.identifier.wosWOS:000419640900007en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherWichtig Publishingen_US
dc.relation.ispartofUrologia Journalen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectComplicationen_US
dc.subjectDiagnosisen_US
dc.subjectProstate Biopsyen_US
dc.subjectProstate Canceren_US
dc.titleComplications and prostate cancer diagnosis rate of TRUS prostate biopsies using 16 and 18G needles by Clavien scoringen_US
dc.typeArticleen_US

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu